Okami Medical Announces Portfolio Expansion with the Addition of the SENDERO® MAX Delivery Catheter
Okami Medical announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the SENDERO MAX Delivery Catheter. This milestone expands Okami's embolization portfolio, which includes the previously cleared SENDERO Microcatheter and LOBO® occluders, providing physicians with a comprehensive, end-to-end, and versatile solution for obstructing blood flow in 1.5mm […]